MBM-02 (Tempol) for the Treatment of Biochemical Recurrent Prostate Cancer
Clinical trial NCT04876755 · UNKNOWN
Trial details
- NCT number
- NCT04876755
- Sponsor
- Matrix Biomed, Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-30
- Primary completion
- 2022-09-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.